| Phase 3 |
| NCT07003074 |
A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the… |
Breast Cancer |
Recruiting |
| NCT07008976 |
Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in… |
Metastatic Breast Cancer |
Recruiting |
| NCT07043725 |
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal… |
HER2-positive Breast Cancer |
Recruiting |
| NCT07047365 |
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer |
HER2-positive Advanced Breast Cancer |
Recruiting |
| NCT07483684 |
A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2… |
HER2 IHC3+ Advanced Colorectal Cancer |
Not Yet Recruiting |
| NCT06297655 |
A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients… |
Hemophilia A |
Active, Not Recruiting |
| NCT07724366 |
A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque… |
Psoriasis |
Not Yet Recruiting |
| Phase 2 |
| NCT06569524 |
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection… |
Non-alcoholic Steatohepatitis |
Recruiting |
| NCT06452706 |
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor… |
Breast Cancer |
Recruiting |
| NCT06962267 |
A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916… |
Pancreatic Cancer |
Recruiting |
| NCT06798207 |
A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With… |
Gynecological Tumors |
Recruiting |
| NCT06767800 |
A Clinical Trial Evaluating TQB2102 for Injection in Combination With… |
Gastroesophageal Adenocarcinoma |
Recruiting |
| NCT06767813 |
Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in… |
Pancreatic Neoplasms |
Recruiting |
| NCT06496490 |
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT07406035 |
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis |
Psoriatic Arthritis |
Recruiting |
| NCT06789289 |
A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate… |
Chronic Obstructive Pulmonary Disease |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07044908 |
TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in… |
RAS/BRAF Wild Type Colorectal Cancer |
Recruiting |
| NCT06825494 |
Clinical Studies for the Treatment of Advanced Solid Tumors |
Advanced Solid Tumor |
Recruiting |
| NCT06431490 |
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer |
Biliary Tract Cancer |
Recruiting |
| NCT07512583 |
Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors |
Advanced Solid Tumor |
Recruiting |
| NCT07653685 |
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the… |
Colorectal Cancer |
Not Yet Recruiting |
| Phase 1 |
| NCT06700395 |
A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma |
Multiple Myeloma |
Recruiting |
| NCT06188624 |
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers |
Advanced Cancer |
Recruiting |
| NCT07113925 |
A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies |
Advanced Hematologic Malignancies |
Recruiting |
| NCT07179679 |
A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in… |
Multiple Myeloma |
Recruiting |